If you need more lookups,
subscriptions start at $34 USD/month.
Eric Guenzi Location
Berlin, DE
Eric Guenzi Work
CEO @ (June 2022 - Present)
VP, Head Non-clinical and Experimental Medicine @ (February 2018 - May 2022)
VP, Head Analytic and Preclinical Development @ (March 2016 - February 2018)
VP, Head Preclinical Development and Project Management @ Baliopharm AG (September 2011 - February 2016)
VP, Head Preclinical Development and Project Management @ (January 2010 - August 2011)
Associate director Immunology @ (September 2005 - December 2009)
Head of department "virus induced vasculopathy" @ (August 1999 - September 2005)
Project leader, Peptide synthetase and Vaccines development @ Chiron Corporation (Novartis Vaccines), Siena, Italy (September 1994 - July 1999)
Post-doc @ Max-Planck institute for molecular genetic, Berlin, Germany (April 1993 - August 1994)
PhD student @ Max-Planck institute for molecular genetic, Berlin, Germany (January 1990 - March 1993)
Eric Guenzi Education
Université Paul Sabatier Toulouse III
PhD (Molecular biology)
1990-1993
Université de Tours
Licence (Physiology animal, biochemistry)
1984-1987
Eric Guenzi Skills
Sales
Data Analysis
Biotechnology
Business Development
Immunology
Healthcare
Strategic Planning
Drug Discovery
Molecular Biology
Lifesciences
Oncology
Clinical Development
Vaccines
Pharmaceutical Industry
Biochemistry
Science
GLP
Toxicology
Biomarkers
Protein Chemistry
Biopharmaceuticals
Eric Guenzi Summary
Eric Guenzi, based in Berlin, DE, is currently a CEO at UGA Biopharma GmbH. Eric Guenzi brings experience from previous roles at Alvotech, Baliopharm AG and Celonic AG. Eric Guenzi holds a 1990 - 1993 PhD in Molecular biology @ Université Paul Sabatier Toulouse III. With a robust skill set that includes Sales, Data Analysis, Biotechnology, Business Development, Immunology and more. Eric Guenzi has 3 emails on RocketReach.
Looking for a different Eric Guenzi?
Find contact details for 700 million professionals.